R&D Heads At GSK & AZ Say Key To Success Lies In Smart Risk Taking

 
• By Sten Stovall

AZ's Mene Pangalos and GSK's Hal Barron are at different stages of overseeing culture changes in their respective R&D workforces - but both agreed at a recent conference that such transformations are key for the future viability of their drug companies.

SWOT
Pair Say R&D needs better decision-making and focused risk-taking • Source: Shutterstock

More from Strategy

More from Business